VGLS — VG Life Sciences Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $2.11m
- $6.11m
Annual balance sheet for VG Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2010 December 31st | C2011 December 31st | R2012 December 31st | 2013 December 31st | 2014 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PRESS | ARS | 10-Q | 10-Q | 10-K |
| Standards: | — | — | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.007 | 0.006 | 0.006 | 0.714 | 0.034 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.016 | 0.009 | 0.006 | 0.789 | 0.246 |
| Net Property, Plant And Equipment | 0 | — | 0 | 0 | 0 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 3.1 | 3.09 | 1.08 | 1.87 | 1.32 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.14 | 2.81 | 5.28 | 6.33 | 5.83 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 5.11 | 4.15 | 5.98 | 7.03 | 6.49 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -2.01 | -1.06 | -4.9 | -5.17 | -5.17 |
| Total Liabilities & Shareholders' Equity | 3.1 | 3.09 | 1.08 | 1.87 | 1.32 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |